Home › Listed IPOs › Himalaya Nutravedics India IPO
Himalaya Nutravedics India IPOLISTED
Himalaya Nutravedics India Limited manufactures, markets and distributes Ayurvedic formulations and nutraceutical supplements, alongside third-party contract manufacturing services.
Listing price
₹118
+11.32%
Current price
—
Not available
Issue price
₹106
Upper band
Listed on
29 Sept 26
HIMALAYANUTRAVEDICSINDIA
- Open22 Sept
- Close24 Sept
- Allotment25 Sept
- Refund28 Sept
- Demat28 Sept
- Listing29 Sept
Listed at
₹118
+11.32% on 29 Sept 26
Overview
Price band
₹100-106
Lot size
1,200 shares
Minimum application 2 lots
Face value
₹10 / share
Issue type
Book Built Issue
Min. investment
₹2,54,400
2 lots · 2,400 shares
Listing at
BSE
Issue Size : 24,99,600 shares worth ₹26.5 Cr
- Fresh Issue : 24,99,600 shares worth ₹26.5 Cr
IPO Share Reservation
Total
94.96%
Lot size & investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | ₹2,54,400 |
| Retail (Max) | 2 | 2,400 | ₹2,54,400 |
| S-HNI (Min) | 3 | 3,600 | ₹3,81,600 |
| S-HNI (Max) | 7 | 8,400 | ₹8,90,400 |
| B-HNI (Min) | 8 | 9,600 | ₹10,17,600 |
Listing performance
Listing gain
+11.32%
Gain per retail lot
₹28,800
Latest vs issue
—
GMP was
—
Latest price shows here when a live quote is available (NSE main-board stocks).
Subscription
- QIB1.00xQIB1.00xQualified Institutional BuyersShares offered 4,74,000Shares applied 4,74,000Bid amount ₹5.02 Cr
- NII (HNI)3.93xNII (HNI)3.93xNon-Institutional InvestorsShares offered 3,56,000Shares applied 14,00,000Bid amount ₹14.84 Cr
- S-HNI3.04xS-HNI3.04xSmall HNI · ₹2L – ₹10LShares offered 1,19,000Shares applied 3,61,000Bid amount ₹3.83 Cr
- B-HNI4.37xB-HNI4.37xBig HNI · above ₹10LShares offered 2,38,000Shares applied 10,39,000Bid amount ₹11.02 Cr
- Retail2.56xRetail2.56xRetail Individual InvestorsShares offered 8,33,000Shares applied 21,34,000Bid amount ₹22.62 Cr
- Total2.41xTotal2.41xAll categories combinedShares offered 16,63,000Shares applied 40,08,000Bid amount ₹42.48 Cr
Financials
| Period(₹ Cr) | Revenue | Expense | PAT | Assets | Borrowing |
|---|---|---|---|---|---|
| Mar 2024 | 14.43 | 13.83 | 0.43 | 6.09 | 3.24 |
| Mar 2025 | 21 | 18.75 | 2.23 | 10.82 | 1.76 |
| Mar 2026 | 43.12 | 35.64 | 7.39 | 24.42 | 5.13 |
KPI & Valuation
Key performance indicators
- ROE
- 63.87%
- PAT Margin
- 17.16%
- ROCE
- 36.41%
- EBITDA Margin
- 18.82%
- Debt to Equity Ratio
- 0.31
- Price to Book Value
- 3.97
- RoNW
- 45.12%
As of 31 Mar 2026
Valuation
- EPS Pre IPO
- ₹11.72
- EPS Post IPO
- ₹8.39
- P/E Pre IPO
- 9.04
- P/E Post IPO
- 12.63
Strengths & risks
Strengths
- Diversified Product Portfolio with classical Ayurvedic, proprietary Ayurvedic and nutraceutical products.
- Hybrid Business Model combining own branded products with third-party contract manufacturing.
- Doctor-Centric Approach supported by a pan-India distribution network.
- WHO-GMP Manufacturing Facility with multiple quality certifications and applicable AYUSH and FSSAI licences.
- Strong Financial Growth with improvement in revenue, EBITDA and PAT over FY2024–FY2026.
Risks
- Limited Operating History as the Company commenced operations only in 2022.
- Single Manufacturing Facility creates dependence on one production location.
- Third-Party Manufacturing Dependence exposes the Company to risks associated with contract manufacturing relationships.
- Trademark Opposition proceedings relating to the Company's corporate trademarks are currently pending.
- Competitive Industry with established players operating across the Ayurvedic and nutraceutical segments.
Objects of the issue
| Purpose | Amount (₹ Cr) |
|---|---|
| Funding Working Capital Requirements. | 13.75 |
| Business Development and Digital Marketing Activities. | 7.5 |
| General Corporate Purposes. | - |
Promoter Holdings
Company Promoter(s)
- Rohit Asawa
- Divya Asawa
- Chanda Asawa
- Rama Raju Penmatsas
Registrar & contacts
Registrar
Kfin Technologies Ltd.
Company
Himalaya Nutravedics India Limited
- Plot No. 101/A, Phase-III, Industrial Development Park, Cherlapally, Hindustan Cables Ltd, Uppal Hyderabad, Telangana, 500051
- +91-9063498493
- info@himalayanutravedics.com
- https://himalayanutravedics.com/
Documents
Lead managers
About Himalaya Nutravedics India
Himalaya Nutravedics India Limited manufactures, markets and distributes Ayurvedic and nutraceutical products in India and also undertakes third-party contract manufacturing. Its portfolio includes classical and proprietary Ayurvedic formulations and nutraceutical supplements across various dosage forms.
The Company follows a hybrid business model combining own branded products with third-party manufacturing. It began manufacturing in September 2022 at its Cherlapally, Hyderabad facility, initially relying mainly on third-party manufacturing before expanding its own product business.
Its own-brand portfolio includes classical and proprietary Ayurvedic formulations and nutraceutical supplements, covering various therapeutic and wellness areas through a doctor-centric marketing approach and pan-India distribution network.
The Company operates a WHO-GMP compliant manufacturing facility in Hyderabad, with certifications and licences including ISO 9001:2015, ISO 22000:2018, FSSAI and AYUSH, supporting its Ayurvedic and nutraceutical product portfolio.
As of July 31, 2026, the Company employed a total of 86 personnel.